Platform
Features
Pricing
1 follower
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.
Industries
Headquarters
Employees
Links
Stephen S. Yoder
20 members
6 members
Tilda
AbbVie
174 followers
CONMED
2 followers
deepc
Edged
Givebutter
4 followers
Silicon Ranch
3 followers
Syndicate
Abbott
278 followers
AstraZeneca
260 followers
Novo Nordisk
246 followers
Explore companies